Establishment Labs Holdings Inc. (NASDAQ:ESTA) Receives $87.00 Consensus PT from Analysts

by · The Markets Daily

Shares of Establishment Labs Holdings Inc. (NASDAQ:ESTA – Get Free Report) have been assigned a consensus rating of “Moderate Buy” from the eight research firms that are presently covering the company, MarketBeat Ratings reports. One analyst has rated the stock with a sell recommendation, one has assigned a hold recommendation and six have issued a buy recommendation on the company. The average 12 month price objective among brokerages that have updated their coverage on the stock in the last year is $87.00.

ESTA has been the topic of a number of recent analyst reports. Weiss Ratings reissued a “sell (e+)” rating on shares of Establishment Labs in a research report on Monday, December 29th. Citigroup increased their price target on Establishment Labs from $62.00 to $75.00 and gave the stock a “neutral” rating in a report on Thursday, December 11th. Mizuho lifted their price objective on Establishment Labs from $90.00 to $100.00 and gave the company an “outperform” rating in a report on Wednesday, February 25th. JPMorgan Chase & Co. increased their target price on Establishment Labs from $71.00 to $80.00 and gave the stock an “overweight” rating in a research note on Wednesday, December 17th. Finally, Wall Street Zen raised shares of Establishment Labs from a “hold” rating to a “buy” rating in a research note on Saturday.

View Our Latest Analysis on ESTA

Institutional Investors Weigh In On Establishment Labs

Several institutional investors have recently added to or reduced their stakes in the stock. Quarry LP bought a new stake in shares of Establishment Labs in the third quarter valued at about $34,000. Kestra Advisory Services LLC bought a new position in shares of Establishment Labs during the 4th quarter worth approximately $47,000. State of Wyoming acquired a new stake in shares of Establishment Labs in the third quarter valued at approximately $71,000. Osaic Holdings Inc. raised its holdings in shares of Establishment Labs by 900.0% in the second quarter. Osaic Holdings Inc. now owns 2,000 shares of the company’s stock valued at $85,000 after purchasing an additional 1,800 shares during the last quarter. Finally, MV Capital Management Inc. bought a new stake in shares of Establishment Labs in the fourth quarter worth $146,000. 72.91% of the stock is owned by institutional investors.

Establishment Labs Price Performance

Establishment Labs stock opened at $69.06 on Thursday. The company has a current ratio of 3.04, a quick ratio of 2.00 and a debt-to-equity ratio of 10.51. The firm has a market capitalization of $2.02 billion, a P/E ratio of -39.69 and a beta of 0.91. The business has a 50-day moving average of $70.81 and a 200-day moving average of $60.03. Establishment Labs has a 1 year low of $26.56 and a 1 year high of $83.31.

Establishment Labs (NASDAQ:ESTA – Get Free Report) last announced its quarterly earnings results on Tuesday, February 24th. The company reported ($0.09) earnings per share for the quarter, beating analysts’ consensus estimates of ($0.22) by $0.13. The business had revenue of $64.62 million for the quarter, compared to the consensus estimate of $63.80 million. Establishment Labs had a negative net margin of 24.19% and a negative return on equity of 201.79%. Establishment Labs’s revenue for the quarter was up 45.2% on a year-over-year basis. During the same period last year, the company posted ($1.19) EPS. On average, equities analysts anticipate that Establishment Labs will post -2.41 EPS for the current year.

Establishment Labs Company Profile

(Get Free Report)

Establishment Labs Holdings Inc is a global medical technology company specializing in the design, development and manufacture of silicone gel breast implants for aesthetic and reconstructive surgery. The company’s proprietary portfolio is built around patient-focused safety, customization and innovation, offering solutions intended to enhance surgical outcomes and support clinical traceability.

The company’s flagship products fall under the Motiva® brand, which includes a range of ergonomic and round breast implants featuring SilkSurface® texturing and an embedded Q Inside® Safety microtransponder for unique implant identification.

Recommended Stories